Biotech entity
Africa Centres for Disease Control and Prevention is the most frequent co-covered peer, appearing in 2 of the 3 tracked stories. Source depth averages 3.3 original sources per story, versus 7.6 across the same-window beat baseline. The clearest coverage concentration is clinical-trial: 2 of 3 stories, with the rest divided among 1 other category.
Last mentioned: Jul 11, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 33 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Africa Centres for Disease Control and Prevention is the most frequent co-covered peer, appearing in 2 of the 3 tracked stories. Source depth averages 3.3 original sources per story, versus 7.6 across the same-window beat baseline. The clearest coverage concentration is clinical-trial: 2 of 3 stories, with the rest divided among 1 other category. The 13-day window averages about 1.6 stories each week. The 6.3 average consequence score is below the beat benchmark of 6.9 in the same window. We currently track 3 Biotech stories that mention US Centers for Disease Control and Prevention, published between July 11, 2026 and July 23, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 63 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering US Centers for Disease Control and Prevention. Shared-story counts are live from our verified record — not editorial picks.
US aid worker tests positive
CDC confirms a US citizen aid worker in Congo has Ebola; contact tracing and containment measures initiated.
Record outbreak data confirmed
Africa CDC reports the outbreak as the fastest-growing ever at 1,830 confirmed cases and 648 deaths. U.S. aid worker infection announced by CDC.
Clinical trials for treatments launched
Researchers initiate a highly anticipated clinical study to test experimental therapies against the Bundibugyo virus.
Clinical trials for Ebola treatment begin
Researchers launch a highly anticipated study to test experimental therapies against the Bundibugyo strain.
Kenya court suspends U.S.-backed facility
A Kenyan court order halts construction of a U.S.-planned quarantine facility for Americans exposed abroad, complicating evacuation plans.
Kenya Ebola facility suspended
A Kenyan court orders suspension of construction on a US-backed isolation facility for exposed Americans, pausing Trump administration plans.
First US doctor infected
An American doctor working in Congo tests positive during outbreak's first week and is transferred to Germany for treatment.
Congo declares fresh Ebola outbreak
Authorities announce outbreak of Bundibugyo virus after weeks of undetected transmission, according to WHO.
Ebola outbreak officially declared
Congolese authorities declare a fresh Ebola outbreak after weeks of undetected transmission, as later confirmed by WHO.
First U.S. doctor infected and evacuated
An American doctor working in Congo tests positive for Ebola and is transferred to Germany for treatment during the outbreak’s first week.
With no approved vaccine or treatment, the rare Bundibugyo ebolavirus driving the Congo outbreak has infected 1,830 people and killed 648. As two U.S. workers fall ill, recently launched clinical trials represent the only hope for a therapeutic breakthrough.
Source: wtvq.com
With 992 infections in Michigan, the cyclospora outbreak creates urgent demand for antibiotic supplies and spotlights the need for novel antiparasitic therapies, presenting both short-term and long-term opportunities for biopharma.
Source: sandiegouniontribune.com · orlandosentinel.com
The Congo Ebola outbreak driven by the rare Bundibugyo virus has ballooned to 1,830 cases with zero approved vaccines or treatments, forcing an urgent launch of clinical trials. For biotech and pharma, this emergency opens a race to develop broad-spectrum filovirus countermeasures.
US Centers for Disease Control and Prevention is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
